Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ENTA holding history

Enanta Pharmaceuticals Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENTA overviewAll 13F holders of ENTAFull Q2 2026 holdings

Shares (Q2 2026)
34,539
Value
$503.6K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ENTA by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202634,539$503.6K<0.1%−36,345−51.3%ReducedHolders
Q1 202670,884$895.3K<0.1%−96,830−57.7%ReducedHolders
Q4 2025167,714$2.64M<0.1%−58,030−25.7%ReducedHolders
Q3 2025225,744$2.70M<0.1%−56,532−20.0%ReducedHolders
Q2 2025282,276$2.13M<0.1%−101,044−26.4%ReducedHolders
Q1 2025383,320$2.12M<0.1%−38,274−9.1%ReducedHolders
Q4 2024421,594$2.42M<0.1%−79,778−15.9%ReducedHolders
Q3 2024501,372$5.19M<0.1%−32,809−6.1%ReducedHolders
Q2 2024534,181$6.93M<0.1%−36,065−6.3%ReducedHolders
Q1 2024570,246$9.96M<0.1%−67,922−10.6%ReducedHolders
Q4 2023638,168$6.01M<0.1%+277,116+76.8%AddedHolders
Q3 2023361,052$4.03M<0.1%+308,503+587.1%AddedHolders
Q2 202352,549$1.12M<0.1%+52,549NewHolders
Q1 20230$00.0%−4,741−100.0%Sold outHolders
Q4 20224,741$220.6K<0.1%00.0%UnchangedHolders
Q3 20224,741$246.0K<0.1%00.0%UnchangedHolders
Q2 20224,741$224.0K<0.1%−1,364−22.3%ReducedHolders
Q1 20226,105$435.0K<0.1%−18,403−75.1%ReducedHolders
Q4 202124,508$1.83M<0.1%+14,172+137.1%AddedHolders
Q3 202110,336$587.0K<0.1%−14,404−58.2%ReducedHolders
Q2 202124,740$1.09M<0.1%−16,444−39.9%ReducedHolders
Q1 202141,184$2.03M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.